James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 23,858 shares at $23.19 ($553K) on 2023-01-31, disclosed to the SEC on 2023-02-02.
Open-market sale of $553k TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.19 | 11,929 | $277K | 50.0% |
| 2 | $23.19 | 11,929 | $277K | 50.0% |
| Total | $23.19 avg | 23,858 | $553K | 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |